AbCellera Biologics Inc vs Mercadolibre Inc — how do they compare? AbCellera Biologics Inc trades at $9.19 (market cap $2.99B), while Mercadolibre Inc trades at $1,930.02 (market cap $98.35B). The key difference: Mercadolibre Inc is far larger — about 32.9× AbCellera Biologics Inc's market cap, and Mercadolibre Inc is trading nearer its 52-week high, AbCellera Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | MELI | |
|---|---|---|
Market Cap | $2.99B | $98.35B |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $2.51K |
52-Week Low | $2.78 | $1.55K |
Enterprise Value | $2.58B | $106.00B |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →